These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2404587

  • 1. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
    Williams JA, Wessels BW, Edwards JA, Kopher KA, Wanek PM, Wharam MD, Order SE, Klein JL.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):974s-979s. PubMed ID: 2404587
    [Abstract] [Full Text] [Related]

  • 2. Targeting and therapy of human glioma xenografts in vivo using radiolabeled antibodies.
    Williams JA, Edwards JA, Wessels BW, Dillehay LE, Wanek PM, Poggenburg JK, Wharam MD, Order SE, Klein JL.
    Int J Radiat Oncol Biol Phys; 1990 Sep 01; 19(3):633-42. PubMed ID: 2170301
    [Abstract] [Full Text] [Related]

  • 3. Targeting of human glioma xenografts in vivo utilizing radiolabeled antibodies.
    Williams JA, Wessels BW, Wharam MD, Order SE, Wanek PM, Poggenburg JK, Klein JL.
    Int J Radiat Oncol Biol Phys; 1990 Jun 01; 18(6):1367-75. PubMed ID: 2370186
    [Abstract] [Full Text] [Related]

  • 4. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 5. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 6. Role of bone marrow transplantation in 90Y antibody therapy of colon cancer xenografts in nude mice.
    Morton BA, Beatty BG, Mison AP, Wanek PM, Beatty JD.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):1008s-1010s. PubMed ID: 2297712
    [Abstract] [Full Text] [Related]

  • 7. Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of the T cell lymphoma EL4.
    Schmidberger H, Buchsbaum DJ, Blazar BR, Everson P, Vallera DA.
    Cancer Res; 1991 Apr 01; 51(7):1883-90. PubMed ID: 2004371
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.
    Cancer Res; 1990 Mar 15; 50(6):1822-7. PubMed ID: 2407345
    [Abstract] [Full Text] [Related]

  • 9. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 10. Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenografts.
    Borchardt PE, Vriesendorp HM, Freedman RS, Quadri SM.
    Cancer Biother Radiopharm; 2004 Feb 15; 19(1):43-51. PubMed ID: 15068610
    [Abstract] [Full Text] [Related]

  • 11. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
    Stein R, Chen S, Haim S, Goldenberg DM.
    Cancer; 1997 Dec 15; 80(12 Suppl):2636-41. PubMed ID: 9406718
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
    Lee YC, Washburn LC, Sun TT, Byrd BL, Crook JE, Holloway EC, Steplewski Z.
    Cancer Res; 1990 Aug 01; 50(15):4546-51. PubMed ID: 2164441
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM, Kaltovich FA, Shih LB, Fand I, Govelitz G, Goldenberg DM.
    Cancer Res; 1988 Jun 01; 48(11):3270-5. PubMed ID: 3365705
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
    Buchsbaum DJ, Lawrence TS, Roberson PL, Heidorn DB, Ten Haken RK, Steplewski Z.
    Int J Radiat Oncol Biol Phys; 1993 Mar 15; 25(4):629-38. PubMed ID: 8454481
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
    Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD.
    Cancer Res; 1988 Feb 01; 48(3):559-66. PubMed ID: 2446747
    [Abstract] [Full Text] [Related]

  • 16. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 17. Interferon enhancement of radioimmunotherapy for colon carcinoma.
    Kuhn JA, Beatty BG, Wong JY, Esteban JM, Wanek PM, Wall F, Buras RR, Williams LE, Beatty JD.
    Cancer Res; 1991 May 01; 51(9):2335-9. PubMed ID: 1901760
    [Abstract] [Full Text] [Related]

  • 18. Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
    Klein JL, Nguyen TH, Laroque P, Kopher KA, Williams JR, Wessels BW, Dillehay LE, Frincke J, Order SE, Leichner PK.
    Cancer Res; 1989 Nov 15; 49(22):6383-9. PubMed ID: 2553255
    [Abstract] [Full Text] [Related]

  • 19. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
    Mayer R, Dillehay LE, Shao Y, Zhang YG, Song S, Bartholomew RM, Mackenson DG, Williams JR.
    Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):147-57. PubMed ID: 7721611
    [Abstract] [Full Text] [Related]

  • 20. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
    Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM.
    Cancer; 1997 Dec 15; 80(12 Suppl):2591-610. PubMed ID: 9406714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.